Morgan Stanley’s Benefitfocus, Inc. BNFT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-343,931
| Closed | -$3.6M | – | 7979 |
|
|
2022
Q4 | $3.6M | Buy |
343,931
+245,082
| +248% | +$2.2M | ﹤0.01% | 4022 |
|
|
2022
Q3 | $628K | Sell |
98,849
-76,213
| -44% | -$565K | ﹤0.01% | 5149 |
|
|
2022
Q2 | $1.36M | Sell |
175,062
-66,025
| -27% | -$652K | ﹤0.01% | 4812 |
|
|
2022
Q1 | $3.04M | Sell |
241,087
-25,974
| -10% | -$277K | ﹤0.01% | 4190 |
|
|
2021
Q4 | $2.85M | Sell |
267,061
-182,139
| -41% | -$1.96M | ﹤0.01% | 4284 |
|
|
2021
Q3 | $4.99M | Sell |
449,200
-212,025
| -32% | -$2.58M | ﹤0.01% | 3711 |
|
|
2021
Q2 | $9.32M | Buy |
661,225
+23,236
| +4% | +$328K | ﹤0.01% | 3073 |
|
|
2021
Q1 | $8.81M | Sell |
637,989
-279,195
| -30% | -$4.02M | ﹤0.01% | 2785 |
|
|
2020
Q4 | $13.3M | Sell |
917,184
-3,796
| -0.4% | -$46.3K | ﹤0.01% | 2223 |
|
|
2020
Q3 | $10.3M | Sell |
920,980
-172,763
| -16% | -$1.9M | ﹤0.01% | 1999 |
|
|
2020
Q2 | $11.8M | Sell |
1,093,743
-172,878
| -14% | -$1.89M | ﹤0.01% | 1822 |
|
|
2020
Q1 | $11.3M | Buy |
1,266,621
+665,348
| +111% | +$10.1M | ﹤0.01% | 1676 |
|
|
2019
Q4 | $13.2M | Buy |
601,273
+74,372
| +14% | +$1.68M | ﹤0.01% | 2096 |
|
|
2019
Q3 | $12.5M | Buy |
526,901
+33,387
| +7% | +$856K | ﹤0.01% | 1895 |
|
|
2019
Q2 | $13.4M | Buy |
493,514
+154,429
| +46% | +$5.18M | ﹤0.01% | 1854 |
|
|
2019
Q1 | $16.8M | Buy |
339,085
+282,135
| +495% | +$14.4M | ﹤0.01% | 1579 |
|
|
2018
Q4 | $2.6M | Buy |
56,950
+19,443
| +52% | +$812K | ﹤0.01% | 3542 |
|
|
2018
Q3 | $1.52M | Sell |
37,507
-7,074
| -16% | -$272K | ﹤0.01% | 4217 |
|
|
2018
Q2 | $1.5M | Buy |
44,581
+9,528
| +27% | +$299K | ﹤0.01% | 4322 |
|
|
2018
Q1 | $855K | Sell |
35,053
-295,785
| -89% | -$7.41M | ﹤0.01% | 4652 |
|
|
2017
Q4 | $8.93M | Sell |
330,838
-14,019
| -4% | -$389K | ﹤0.01% | 2514 |
|
|
2017
Q3 | $11.6M | Buy |
344,857
+80,974
| +31% | +$2.59M | ﹤0.01% | 2132 |
|
|
2017
Q2 | $9.59M | Sell |
263,883
-27,343
| -9% | -$877K | ﹤0.01% | 2220 |
|
|
2017
Q1 | $8.14M | Sell |
291,226
-87,172
| -23% | -$2.5M | ﹤0.01% | 2408 |
|
|
2016
Q4 | $11.2M | Sell |
378,398
-67,334
| -15% | -$2.15M | ﹤0.01% | 2124 |
|
|
2016
Q3 | $17.8M | Sell |
445,732
-18,547
| -4% | -$761K | 0.01% | 1551 |
|
|
2016
Q2 | $17.7M | Sell |
464,279
-94,400
| -17% | -$3.44M | 0.01% | 1517 |
|
|
2016
Q1 | $18.6M | Sell |
558,679
-92,899
| -14% | -$2.77M | 0.01% | 1354 |
|
|
2015
Q4 | $23.7M | Sell |
651,578
-405,525
| -38% | -$14.4M | 0.01% | 1272 |
|
|
2015
Q3 | $33M | Buy |
1,057,103
+19,663
| +2% | +$752K | 0.01% | 1037 |
|
|
2015
Q2 | $45.5M | Sell |
1,037,440
-18,364
| -2% | -$693K | 0.02% | 921 |
|
|
2015
Q1 | $38.8M | Sell |
1,055,804
-134,377
| -11% | -$4.02M | 0.01% | 997 |
|
|
2014
Q4 | $39.1M | Sell |
1,190,181
-135,133
| -10% | -$3.56M | 0.01% | 997 |
|
|
2014
Q3 | $35.7M | Sell |
1,325,314
-31,997
| -2% | -$1.17M | 0.01% | 1006 |
|
|
2014
Q2 | $62.7M | Buy |
1,357,311
+83,503
| +7% | +$3.13M | 0.02% | 686 |
|
|
2014
Q1 | $59.8M | Buy |
1,273,808
+18,990
| +2% | +$1.19M | 0.03% | 669 |
|
|
2013
Q4 | $72.5M | Buy |
+1,254,818
| New | +$61.1M | 0.03% | 569 |
|
Other funds holding BNFT
Morgan Stanley's BNFT Position: Q1 2023 in Review
Morgan Stanley sold out of Benefitfocus, Inc. (BNFT) in Q1 2023, closing a stake of 343,931 shares — an estimated $3.6M sold.
Morgan Stanley first reported a position in BNFT in Q4 2013 and held it in 37 quarters. The position peaked at $72.5M in Q4 2013. 1 fund tracked by Wall St. Rank holds BNFT as of Q1 2023.
- Morgan Stanley reported no remaining Benefitfocus, Inc. position as of Q1 2023 after selling out during the quarter.
- Morgan Stanley sold 343,931 Benefitfocus, Inc. shares in Q1 2023, an estimated $3.6M.
- Morgan Stanley first reported a position in Benefitfocus, Inc. in Q4 2013 and held it in 37 quarters.
- Morgan Stanley's Benefitfocus, Inc. position peaked at $72.5M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Benefitfocus, Inc. as of Q1 2023.
Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.